|
2025
|
P/S
|
Pharmaceutical and biological preparations for human use. |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metab... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases,... |
|
|
Invention
|
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling.
The disclosure provides a method for im... |
|
|
Invention
|
Quinazolines as potassium ion channel inhibitors.
A compound of formula I
A compound of formul... |
|
|
Invention
|
Process for the preparation of a cyclic dinucleotide.
The invention generally relates to an impr... |
|
|
Invention
|
Antifoam compositions and methods of use thereof. The present disclosure provides compositions an... |
|
|
Invention
|
Bicyclic tlr7 agonists and uses thereof. Compounds according to Formula (I) are useful as agonist... |
|
|
Invention
|
Tricyclic tlr7 agonists and uses thereof. Compounds according to Formula (I) are useful as agonis... |
|
|
Invention
|
Tricyclic tlr7 agonists and uses thereof.
Compounds according to Formula (I) are useful as agoni... |
|
|
Invention
|
Bicyclic tlr7 agonists and uses thereof.
Compounds according to Formula (I) are useful as agonis... |
|
|
Invention
|
Anti-ceacam5 antibodies and uses thereof. Provided herein are isolated anti-CEACAM5 antibodies, a... |
|
|
Invention
|
Anti-ceacam5 antibody drug conjugates. Provided herein are antibody drug conjugates of the formul... |
|
|
Invention
|
Anti-ceacam5 antibody drug conjugates.
Provided herein are antibody drug conjugates of the formu... |
|
|
Invention
|
Anti-cd33 antibodies and uses thereof. The present application relates to particular anti-CD33 an... |
|
|
Invention
|
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins.
The present disclosure pr... |
|
|
Invention
|
Anti-lag-3 antibodies to treat hematological malignancies.
Provided are methods for clinical tre... |
|
|
Invention
|
Methods of treating cancer with antibodies against tim3.
This disclosure provides a method for t... |
|
|
Invention
|
Antisense oligonucleotides targeting alpha-synuclein and uses thereof.
The present disclosure re... |
|
|
Invention
|
Tim-3 antagonists for the treatment and diagnosis of cancers.
Provided herein are methods for tr... |
|
|
Invention
|
Ligand directed degrader of irak4. Provided herein is a compound of the following structural form... |
|
|
Invention
|
Heteroaryl compounds as ligand directed degraders of irak4. Provided herein are compounds (I) and... |
|
2024
|
Invention
|
Combination therapy of kras inhibitor and treg depleting agent.
In some aspects, the present dis... |
|
|
Invention
|
Combination therapy of kras inhibitor and treg-depleting agent. In some aspects, the present disc... |
|
|
Invention
|
Antibodies targeting il-18 receptor beta (il-18rb) and related methods.
Provided are novel antib... |
|
|
Invention
|
Antibodies targeting il-18 receptor beta (il-18rβ) and related methods. Provided are novel antibo... |
|
|
Invention
|
Wee1 degrading compounds and uses thereof. Provided herein are compounds and compositions thereof... |
|
|
Invention
|
Leveraging large language models for automating lines of therapy adjudication in cancer patients.... |
|
|
Invention
|
Wee1 degrading compounds and uses thereof.
Provided herein are compounds and compositions thereo... |
|
|
Invention
|
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use.
Disclosed herein ... |
|
|
Invention
|
Kras g12c inhibitors. The present disclosure provides KRAS inhibitors of formula (I). Methods of ... |
|
|
Invention
|
Antibodies binding to vista at acidic ph.
The present application relates to antibodies specific... |
|
|
Invention
|
Machine-learning models for prognosing outcomes for hypertrophic cardiomyopathy (hcm). A computer... |
|
|
Invention
|
Machine-learning models for prognosing outcomes for hypertrophic cardiomyopathy (hcm).
A compute... |
|
|
Invention
|
Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha re... |
|
2023
|
Invention
|
Kras inhibitors.
The present disclosure provides KRAS inhibitors. Methods of treating cancers us... |
|
|
Invention
|
Drug delivery device with hidden marking.
The subject invention is for use with various drug del... |
|
|
Invention
|
Combination therapy using a substituted pyrimidin-4(3h)-one and nivolumab as well as its use in t... |
|
|
Invention
|
Processes for preparation of 3-d printed pharmaceutical products.
This invention relates to meth... |
|
|
Invention
|
Macrocyclic immunomodulators.
In accordance with the present disclosure, macrocyclic compounds h... |
|
|
Invention
|
Pharmaceutical compositions for improving oral bioavailability.
In accordance with the present d... |
|
|
Invention
|
Methods of isolating polypeptides.
The present disclosure is directed methods of isolating and/o... |
|
|
Invention
|
Transient expression of therapeutic proteins.
The present disclosure provide novel methods of la... |
|
|
Invention
|
Combination therapy for colorectal carcinoma.
The invention provides a method of treating a colo... |
|
|
Invention
|
Substituted imidazopyridinyl compounds useful as inhibitors of tlr9.
Disclosed are compounds of ... |
|
|
Invention
|
Combination therapy for hepatocellular carcinoma.
The disclosure provides a method of treating a... |
|
2022
|
Invention
|
Rxfp1 agonists.
The disclosure relates to compounds of Formula (I), which are RXFP1 receptor ago... |
|
|
Invention
|
2,3-dihydrobenzo[b][1,4]dioxin-6-yl containing compounds useful as immunomodulators.
The present... |
